Physician profile
Dana E Bragg
NPI 1598746562
$3,366.39
in general payments reported to CMS, 2019-2025
36 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $633 · 2021: $671 · 2022: $589 · 2023: $545 · 2024: $332 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $579.61 | 2020-2025 | Ubrelvy, Vraylar, Qulipta |
| Amarin Pharma, INC. | $421.34 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $234.36 | 2020-2023 | Brilinta |
| Allergan, INC. | $181.31 | 2019-2020 | |
| Pfizer INC. | $166.41 | 2019-2024 | |
| Novo Nordisk INC | $155.50 | 2019-2022 | |
| Astellas Pharma US INC | $154.80 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $108.17 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.52 | 2019-2023 | Xifaxan |
| Daiichi Sankyo INC. | $98.83 | 2020-2022 | |
| Lilly USA, LLC | $94.78 | 2019-2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $94.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $80.83 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $72.37 | 2021 | |
| Dexcom, INC. | $70.28 | 2021-2024 | Dexcom G6 Transmitter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $70.20 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.93 | 2019-2024 | |
| Amgen INC. | $66.45 | 2019-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $60.64 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $58.96 | 2020-2021 | |
| Abbott Laboratories | $55.66 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $48.84 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.27 | 2020-2021 | |
| Insulet Corporation | $43.94 | 2023-2024 | Omnipod |
| Esperion Therapeutics, INC. | $29.89 | 2020-2024 | Nexletol |
| Glaxosmithkline, LLC. | $21.26 | 2022 | |
| Phathom Pharmaceuticals, INC. | $20.21 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.00 | 2022 | |
| Scilex Pharmaceuticals INC. | $19.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.17 | 2023 | Eliquis |
| Jazz Pharmaceuticals INC. | $18.88 | 2019 | |
| Lundbeck LLC | $18.30 | 2024 | Rexulti |
| Philips North America LLC | $16.42 | 2022 | |
| Ethicon US, LLC | $15.29 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.08 | 2022 | |
| Redhill Biopharma INC. | $14.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Bragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.